Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #947 | December 10, 2021  
Children's Hospital Colorado

New Colorado Pediatric Scleroderma Center

Children's Hospital Colorado, Section of Pediatric Rheumatology has been designated as a Scleroderma Research & Treatment Center by the Foundation's Medical & Scientific Advisory Board. The center accepts referrals for localized scleroderma/morphea, systemic sclerosis, stiff skin syndrome, and other sclerosing diseases. New cases accepted up to 18 years of age.

READ

Lap Top Little Guy

Strategic Plan Update

ZOOM: January 13, 2022; 2 PM Eastern

Join CEO Mary J. Wheatley to hear an update on the Foundation's strategic plan. Learn about progress in our exciting work to strengthen our organization and to build capacity for growth in support of individuals affected by scleroderma, to expand our education programs, and to build greater resources for research funding.

REGISTER

HealthCare.gov logo

Dates & Deadlines for 2022 Health Insurance

You can enroll in or change 2022 Marketplace health insurance right now on HealthCare.gov

December 15, 2021 is the last day to enroll in or change plans for 2022 coverage that starts January 1, 2022.

After that, January 15, 2022 is the last day to enroll in or change plans for 2022 coverage (for coverage starting February 1, 2022). After this date, you can enroll or change plans only if you qualify for a Special Enrollment Period.

HEALTHCARE.GOV

SYNC Meet Up December 2021

Scleroderma Young Adults Needing Connection (SYNC)

VIRTUAL: December 17, 2021; 7 PM Eastern

Young adults between the ages of 18 and 42 who seek connection with others their age are invited to attend the SYNC Meet Up on December 17 for "All things holiday!" Wear your best ugly sweater and let's celebrate!

REGISTER

Michigan December 2021 Men

The 20%: A Virtual Support Group for Males Living with Scleroderma

VIRTUAL: December 22, 2021; 7-8 PM Eastern
TOPIC: What is All the Fuss About?

To support the men with scleroderma in our community, the Michigan Chapter hosts a virtual support group just for men. Join the December 22 virtual group from 7 to 8 p.m. Eastern. The topic, What is all the fuss about?, offers reflections, tips, and tricks. There is time for questions at the end. Register now and find support and hope in the community.

REGISTER

YouTube 2021 Conference COVID Gordon Spiera

COVID-19 Update

VIDEO: Recorded July 2021

Watch this presentation with COVID-19 updates recorded during the 2021 virtual National Scleroderma Conference with Jessica Gordon, MD, MSc, and Robert Spiera, MD, of the Hospital for Special Surgery in New York City. Drs. Gordon and Spiera discuss vaccinations and other important health updates. 

WATCH

YouTube 2021 KGS2 Complications Localized Li

Common Complications in Juvenile Localized Scleroderma, General Health Guidelines

VIDEO: Recorded October 2021

Watch this presentation from the 2021 virtual Kids Get Scleroderma, Too! Conference with Suzanne Li, MD, of the Joseph M. Sanzari Children's Hospital, who discusses common complications in juvenile localized scleroderma.

WATCH

ILD Day 2021 Survey

ILD Day Survey

We need your insights! Please take our short online survey to help us learn more about ILD awareness and perceptions. Your responses will be anonymous and it should take less than five minutes. The information will help create educational materials and programs for the future. This survey was developed in collaboration with Boehringer Ingelheim Pharmaceuticals, Inc.

SURVEY

Poole Recruitment Fatigue 2021 full flyer

Research Study to Evaluate an Online Fatigue Intervention Program

Researchers from the University of New Mexico seek participants for a study to evaluate an online fatigue intervention program for adults. To participate, be a U.S. resident, 18 or older, have systemic sclerosis (SSc, systemic scleroderma). Study involves attending and participating in a 1½ hour virtual meeting once a week for 6 weeks, completing questionnaires at the start and end of study, and an interview at the conclusion. Compensation is offered.

CONTACT: Janet Poole, Ph.D., O.T.R./L., jpoole@salud.unm.edu, (505) 272-8276, or Kristine Carandang, O.T.R./L., carandangkm@gmail.com, (626) 722-8761.

Advertisement
Mitsubishi Tenabe Decode Ad 2021
Advertisement
Kadmon Ad eLetter 2021
 
 
 
QUICK LINKS
Advocacy
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Make a Gift
Home
 
SOCIAL MEDIA
Facebook Twitter Instagram YouTube linkedin-icon
 
SPONSORS
 
National Sponsors

Platinum Corporate Sponsor

Janssen

 

Gold Corporate Sponsors

Boehringer Ingelheim Plain

Horizon Therapeutics logo

 

 

 

 

Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2024 All rights reserved.